PATENT CLAIM ANALYSIS

Application Number: 15775813
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "021700"]

Abstract:
The present invention relates to a nasal administration composition for preventing or treating ischemic cerebrovascular disease, containing a Fas targeting peptide (FTP). When using the pharmaceutical composition or kit of the present invention, a drug can be effectively delivered to brain tissue and the ischemic cerebrovascular disease of a subject can be effectively prevented or treated.

Claim (Index 5):
The pharmaceutical composition of  claim 1 , wherein the ischemic cerebrovascular disease comprises cerebral thrombosis, a cerebral embolism, or lacunar infarction.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 93.0
- Lexical Diversity: 1.47619
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13184378', '14426832', '12025673', '13621977', '13924283']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6761358064646578
- 35 USC 102 Novelty (BERT): 0.516449726349194
- Combined Prediction Score: 0.6601671984531114
- Mean Citation Score: 244.91558
- Max Citation Score: 257.5464
- Similarity Product: 174.17075250120163

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test